208 related articles for article (PubMed ID: 26750255)
1. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
2. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
Estevez Y; Quiliano M; Burguete A; Cabanillas B; Zimic M; Málaga E; Verástegui M; Pérez-Silanes S; Aldana I; Monge A; Castillo D; Deharo E
Exp Parasitol; 2011 Apr; 127(4):745-51. PubMed ID: 21272583
[TBL] [Abstract][Full Text] [Related]
3. Trypanocidal Activity of Quinoxaline 1,4 Di-N-oxide Derivatives as Trypanothione Reductase Inhibitors.
Chacón-Vargas KF; Nogueda-Torres B; Sánchez-Torres LE; Suarez-Contreras E; Villalobos-Rocha JC; Torres-Martinez Y; Lara-Ramirez EE; Fiorani G; Krauth-Siegel RL; Bolognesi ML; Monge A; Rivera G
Molecules; 2017 Feb; 22(2):. PubMed ID: 28157150
[TBL] [Abstract][Full Text] [Related]
4. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, 2D-QSAR Studies and Biological Evaluation of Quinazoline Derivatives as Potent Anti-Trypanosoma cruzi Agents.
Bollini M; Bruno AM; Niño ME; Casal JJ; Sasiambarrena LD; Valdez DAG; Battini L; Puente VR; Lombardo ME
Med Chem; 2019; 15(3):265-276. PubMed ID: 30295191
[TBL] [Abstract][Full Text] [Related]
6. New oxirane derivatives of 1,4-naphthoquinones and their evaluation against T. cruzi epimastigote forms.
Carneiro PF; do Nascimento SB; Pinto AV; Pinto Mdo C; Lechuga GC; Santos DO; dos Santos Júnior HM; Resende JA; Bourguignon SC; Ferreira VF
Bioorg Med Chem; 2012 Aug; 20(16):4995-5000. PubMed ID: 22795899
[TBL] [Abstract][Full Text] [Related]
7. A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.
Rodrigues JH; Ueda-Nakamura T; Corrêa AG; Sangi DP; Nakamura CV
PLoS One; 2014; 9(1):e85706. PubMed ID: 24465654
[TBL] [Abstract][Full Text] [Related]
8. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Vicente E; Duchowicz PR; Benítez D; Castro EA; Cerecetto H; González M; Monge A
Bioorg Med Chem Lett; 2010 Aug; 20(16):4831-5. PubMed ID: 20634064
[TBL] [Abstract][Full Text] [Related]
9. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
Torres E; Moreno-Viguri E; Galiano S; Devarapally G; Crawford PW; Azqueta A; Arbillaga L; Varela J; Birriel E; Di Maio R; Cerecetto H; González M; Aldana I; Monge A; Pérez-Silanes S
Eur J Med Chem; 2013 Aug; 66():324-34. PubMed ID: 23811257
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and molecular docking studies of novel N-arylsulfonyl-benzimidazoles with anti Trypanosoma cruzi activity.
Miana GE; Ribone SR; Vera DMA; Sánchez-Moreno M; Mazzieri MR; Quevedo MA
Eur J Med Chem; 2019 Mar; 165():1-10. PubMed ID: 30641409
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of 2-hydroxy-3-phenylsulfanylmethyl-[1,4]-naphthoquinone derivatives against different Trypanosoma cruzi discrete type units: Identification of a promising hit compound.
Lara LS; Moreira CS; Calvet CM; Lechuga GC; Souza RS; Bourguignon SC; Ferreira VF; Rocha D; Pereira MCS
Eur J Med Chem; 2018 Jan; 144():572-581. PubMed ID: 29289882
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
[TBL] [Abstract][Full Text] [Related]
16. In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-
González-González A; Sánchez-Sánchez O; Krauth-Siegel RL; Bolognesi ML; Gớmez-Escobedo R; Nogueda-Torres B; Vázquez-Jiménez LK; Saavedra E; Encalada R; Espinoza-Hicks JC; Paz-González AD; Rivera G
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362102
[TBL] [Abstract][Full Text] [Related]
17. Induction of programmed cell death in Trypanosoma cruzi by Lippia alba essential oils and their major and synergistic terpenes (citral, limonene and caryophyllene oxide).
Moreno ÉM; Leal SM; Stashenko EE; García LT
BMC Complement Altern Med; 2018 Jul; 18(1):225. PubMed ID: 30053848
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, 3D-QSAR analysis and biological evaluation of quinoxaline 1,4-di-N-oxide derivatives as antituberculosis agents.
Pan Y; Li P; Xie S; Tao Y; Chen D; Dai M; Hao H; Huang L; Wang Y; Wang L; Liu Z; Yuan Z
Bioorg Med Chem Lett; 2016 Aug; 26(16):4146-53. PubMed ID: 27426298
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of isoxazolyl-sulfonamides: A non-cytotoxic scaffold active against Trypanosoma cruzi, Leishmania amazonensis and Herpes Simplex Virus.
da Rosa R; Zimmermann LA; de Moraes MH; Schneider NFZ; Schappo AD; Simões CMO; Steindel M; Schenkel EP; Bernardes LSC
Bioorg Med Chem Lett; 2018 Nov; 28(20):3381-3384. PubMed ID: 30194008
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of in vitro and in vivo trypanocidal properties of a new imidazole-containing nitrophthalazine derivative.
Olmo F; Gómez-Contreras F; Navarro P; Marín C; Yunta MJ; Cano C; Campayo L; Martín-Oliva D; Rosales MJ; Sánchez-Moreno M
Eur J Med Chem; 2015 Dec; 106():106-19. PubMed ID: 26523668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
